{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:07:08Z","timestamp":1778220428141,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007308","name":"SMA","doi-asserted-by":"publisher","award":["2016"],"award-info":[{"award-number":["2016"]}],"id":[{"id":"10.13039\/501100007308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ejpn.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T12:01:06Z","timestamp":1535976066000},"page":"944-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Prenatal aspects in spinal muscular atrophy: From early detection to early presymptomatic intervention"],"prefix":"10.1016","volume":"22","author":[{"given":"Eduardo F.","family":"Tizzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Zafeiriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2018.08.009_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2011.134","article-title":"Pan-ethic Carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of > 72,400 specimens","volume":"20","author":"Sugarman","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ejpn.2018.08.009_bib2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/cge.12222","article-title":"Improving detection and genetic counseling in carriers of Spinal Muscular Atrophy with two copies of the SMN1 gene","volume":"85","author":"Al\u00edas","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejpn.2018.08.009_bib3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"ENDEAR study group. Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejpn.2018.08.009_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejpn.2018.08.009_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part 1:Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2018.08.009_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting (26-28 June 1992, Bonn, Germany)","volume":"2","author":"Munsat","year":"1992","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2018.08.009_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/gt.2017.52","article-title":"The clinical landscape for SMA in a new therapeutic era","volume":"24","author":"Talbot","year":"2017","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejpn.2018.08.009_bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","article-title":"Observational study of spinal muscular atrophy type I and implications for clinical trials","volume":"83","author":"Finkel","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ejpn.2018.08.009_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ana.25101","article-title":"Natural history of infantile-onset spinal muscular atrophy","volume":"82","author":"Kolb","year":"2017","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.ejpn.2018.08.009_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JND-160177","article-title":"Type 0 spinal muscular atrophy: further delineation of prenatal and postnatal features in 16 patients","volume":"3","author":"Grotto","year":"2016","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.ejpn.2018.08.009_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.nmd.2005.07.005","article-title":"134th ENMC international workshop: outcome measures and treatment of spinal muscular atrophy, 11-13 February 2005, Naarden, The Netherlands","volume":"15","author":"Bertini","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2018.08.009_bib12","first-page":"723","article-title":"Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina","volume":"60","author":"Medrano","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2018.08.009_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/jnnp-2016-314292","article-title":"Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4","volume":"88","author":"Wadman","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ejpn.2018.08.009_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2,834 reported cases","volume":"28","author":"Calucho","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2018.08.009_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications","volume":"52","author":"Zerres","year":"1995","journal-title":"Arch Neurol"},{"issue":"Pt A","key":"10.1016\/j.ejpn.2018.08.009_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2018.02.022","article-title":"Spinal muscular atrophy: selective motor neuron loss and global defect in the assembly of ribonucleoproteins","volume":"1693","author":"Beattie","year":"2018","journal-title":"Brain Res"},{"key":"10.1016\/j.ejpn.2018.08.009_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy- determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejpn.2018.08.009_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00439-008-0598-1","article-title":"Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene","volume":"125","author":"Al\u00edas","year":"2009","journal-title":"Hum Genet"},{"issue":"11","key":"10.1016\/j.ejpn.2018.08.009_bib19","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ejpn.2018.08.009_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nmd.2011.03.009","article-title":"Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings","volume":"21","author":"Bernal","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2018.08.009_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/uog.15947","article-title":"Targeted sequencing of maternal plasma for haplotype-based non-invasive prenatal testing of spinal muscular atrophy","volume":"49","author":"Chen","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejpn.2018.08.009_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ejhg.2016.195","article-title":"Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage","volume":"25","author":"Parks","year":"2017","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10.1016\/j.ejpn.2018.08.009_bib23","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1046\/j.1471-0528.2002.02083.x","article-title":"Prenatal diagnosis for risk of spinal muscular atrophy","volume":"109","author":"Cusc\u00f3","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ejpn.2018.08.009_bib24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.nmd.2017.05.011","article-title":"Spinal muscular atrophy: a changing phenotype beyond the clinical trials","volume":"27","author":"Tizzano","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.ejpn.2018.08.009_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2007.07.1305","article-title":"Efficient strategies for preimplantation genetic diagnosis of spinal muscular atrophy","volume":"90","author":"Girardet","year":"2008","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejpn.2018.08.009_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017067","article-title":"Carrier screening for spinal muscular atrophy (SMA) in 107,611pregnant women during the period 2005-2009: a prospective population-based cohort study","volume":"6","author":"Su","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejpn.2018.08.009_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1090-3798(99)80015-4","article-title":"Prenatal onset spinal muscular atrophy","volume":"3","author":"MacLeod","year":"1999","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2018.08.009_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nmd.2010.09.010","article-title":"Ultrasound evaluation of fetal movements in pregnancies at risk for severe spinal muscular atrophy","volume":"21","author":"Parra","year":"2011","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"10.1016\/j.ejpn.2018.08.009_bib29","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3109\/14767058.2011.636101","article-title":"Evaluation of fetal nuchal translucency in 98 pregnancies at risk for severe spinal muscular atrophy: possible relevance of the SMN2 copy number","volume":"25","author":"Parra","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"10.1016\/j.ejpn.2018.08.009_bib30","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/7.12.1927","article-title":"The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy","volume":"7","author":"Burlet","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejpn.2018.08.009_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/64.3.215","article-title":"Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function?","volume":"64","author":"Soler-Botija","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ejpn.2018.08.009_bib32","doi-asserted-by":"crossref","first-page":"11696","DOI":"10.1038\/srep11696","article-title":"Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons","volume":"5","author":"Boza-Mor\u00e1n","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejpn.2018.08.009_bib33","series-title":"Spinal muscular atrophy dis. Mech. Ther","first-page":"21","article-title":"Developmental aspects and pathological findigins in spinal muscular atrophy","author":"Perez Garcia","year":"2017"},{"key":"10.1016\/j.ejpn.2018.08.009_bib34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron","volume":"19","author":"Hamilton","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejpn.2018.08.009_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"72","key":"10.1016\/j.ejpn.2018.08.009_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci Transl Med"},{"issue":"7367","key":"10.1016\/j.ejpn.2018.08.009_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"issue":"6197","key":"10.1016\/j.ejpn.2018.08.009_bib38","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ejpn.2018.08.009_bib39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"CHERISH study group. Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejpn.2018.08.009_bib40","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.ejpn.2017.04.1218","article-title":"Efficacy and safety of nusinersen in infants with presymptomatic spinal muscular atrophy (SMA): interim results from the NURTURE study","volume":"21","author":"Bertini","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2018.08.009_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/JND-180315","article-title":"Evaluation of children with SMA type 1 under treatment with nusinersen within the expanded access program in Germany","volume":"5","author":"Pechmann","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"9","key":"10.1016\/j.ejpn.2018.08.009_bib42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jnnp-2017-317412","article-title":"Nusinersen for SMA: expanded access programme","volume":"89","author":"Farrar","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"18","key":"10.1016\/j.ejpn.2018.08.009_bib43","first-page":"30283","article-title":"Italian EAP working group. Nusinersen in type 1 SMA infants, children and young adults: preliminary results on motor function","author":"Pane","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2018.08.009_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/j.semperi.2015.03.006","article-title":"Newborn screening for spinal muscular atrophy: anticipating an imminent need","volume":"39","author":"Phan","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ejpn.2018.08.009_bib45","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/gim.2017.152","article-title":"Pilot study of population-based newborn screening for spinal muscular atrophy in New York state","volume":"20","author":"Kraszewski","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.ejpn.2018.08.009_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JND-180304","article-title":"Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening","volume":"5","author":"Glascock","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.ejpn.2018.08.009_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcf.2016.04.001","article-title":"The benefits of newborn screening for cystic fibrosis: the Canadian experience","volume":"15","author":"Mak","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ejpn.2018.08.009_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00415-005-0912-y","article-title":"SMN2 copy number predicts acute or chronic spinal muscular atrophy but does not account for intrafamilial variability in siblings","volume":"253","author":"Cusc\u00f3","year":"2006","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.ejpn.2018.08.009_bib49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.ejpn.2018.08.009_bib50","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/brain\/awf155","article-title":"Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord","volume":"125","author":"Soler-Botija","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2018.08.009_bib51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.nmd.2004.11.006","article-title":"Choline acetyltransferase expression does not identify early pathogenic events in fetal SMA spinal cord","volume":"15","author":"Soler-Botija","year":"2005","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.ejpn.2018.08.009_bib52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-002-0566-0","article-title":"Motoneuron death in normal and spinal muscular atrophy-affected human fetuses","volume":"104","author":"Fidzianska","year":"2002","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.ejpn.2018.08.009_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.4080","article-title":"Synaptic defects in type I spinal muscular atrophy in human development","volume":"229","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.ejpn.2018.08.009_bib54","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/NEN.0b013e3181a10ea1","article-title":"The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation","volume":"68","author":"Martinez-Hernandez","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.ejpn.2018.08.009_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/NEN.0000000000000078","article-title":"Abnormalities in earlymarkers of muscle involvement support a delay in myogenesis in spinal muscular atrophy","volume":"73","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.ejpn.2018.08.009_bib56","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2018.08.009_bib57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nmd.2012.09.006","article-title":"Electrophysiological and motor function scale association in a pre-symptomatic infant with spinal muscular atrophy type I","volume":"23","author":"Finkel","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2018.08.009_bib58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/acn3.283","article-title":"Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study","volume":"3","author":"Kolb","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ejpn.2018.08.009_bib59","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jcmm.13450","article-title":"miRNA in spinal muscular atrophy pathogenesis and therapy","volume":"22","author":"Magri","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ejpn.2018.08.009_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060113","article-title":"SMA-MAP: a plasma protein panel for spinal muscular atrophy","volume":"8","author":"Kobayashi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpn.2018.08.009_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: a candidate biomarker of pre-symptomatic ALS and phenoconversion","author":"Benatar","year":"2018","journal-title":"Ann Neurol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379818303386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379818303386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:35:52Z","timestamp":1761071752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379818303386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1090379818303386"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2018.08.009","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal aspects in spinal muscular atrophy: From early detection to early presymptomatic intervention","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2018.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}